As of 05/20/2025, Bayer Aktiengesellschaft's market capitalization has reached $25.28 B. According to our data, Bayer Aktiengesellschaft is the 844th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Bayer Aktiengesellschaft has seen its market value drop from €47.31 B to €22.51 B since 2020, representing a total decrease of 52.41% and an annual compound decline rate (CAGR) of 15.57%.
Date
Market Cap
Change (%)
05/20/2025
€22.51 B
18.39%
12/30/2024
€18.97 B
-42.57%
12/29/2023
€33.04 B
-30.41%
12/30/2022
€47.48 B
2.82%
12/30/2021
€46.17 B
-2.4%
12/30/2020
€47.31 B
Company Profile
Bayer Aktiengesellschaft was founded in 1863 in Germany.
on the Deutsche Börse Xetra.
With 90587 employees, it focuses on Healthcare and aims to drive innovation in Drug Manufacturers - General.
Frequently Asked Questions
As of 05/20/2025, Bayer Aktiengesellschaft (including the parent company, if applicable) has an estimated market capitalization of $25.28 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Bayer Aktiengesellschaft global market capitalization ranking is approximately 844 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.